CRISPR Researchers to Benefit from COBO Technologies and SCIEX Partnership
05-07-2019
"A co-marketing agreement between the two companies will offer PIPPR, a unique protein expression analysis platform, developed for CRISPR applications and powered by SWATH® Acquisition. PIPPR is uniquely and specifically designed to help CRISPR researchers"
Read full Press Release here.
Sign-Up COBO-Q Newsletter and receive the latest updates within Quality Control Genome Editing.
Tags
CRISPRCRISPRQCGenome EditingPIPPRProteomic AnalysisQuality Control Genome Editing